61
1994
Association between smoking and health outcomes in an economically deprived population: the Liverpool Lung Project.

F C Sherratt , J K Field , M W Marcus
Journal of Epidemiology and Community Health 71 ( 8) 806 -810

5
2017
Telomerase activity in non-small cell lung carcinomas correlates with smoking status

G Xinarianos , F M Scott , T Liloglou , W Prime
International Journal of Oncology 15 ( 5) 961 -966

23
1999
Peptide amidating activity in human bronchoalveolar lavage fluid: relationship to lung cancer, inflammation and infection.

F M Scott , W Prime , M Walshaw , L Turnbull
International Journal of Oncology 16 ( 2) 327 -359

2
2000
38
2000
c‐mos immunoreactivity is an indicator of good prognosis in lung cancer

A Athanasiou , V G Gorgoulis , P Zacharatos , G Mariatos
Histopathology 37 ( 1) 45 -54

7
2000
The LLP risk model: an individual risk prediction model for lung cancer.

A Cassidy , J P Myles , M van Tongeren , R D Page
British Journal of Cancer 98 ( 2) 270 -276

464
2008
Comparison of discriminatory power and accuracy of three lung cancer risk models

A M D'Amelio , A Cassidy , K Asomaning , O Y Raji
British Journal of Cancer 103 ( 3) 423 -429

55
2010
Lung cancer screening: the way forward.

J K Field , S W Duffy
British Journal of Cancer 99 ( 4) 557 -562

55
2008
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer

R J Shaw , M M Omar , S Rokadiya , F A Kogera
British Journal of Cancer 101 ( 1) 139 -144

48
2009
Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q

K-R Muehlbauer , J K Field , M von Brevern , M C Hollstein
Oncogene 17 ( 16) 2101 -2105

34
1998
Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer

J Dunn , J Garde , K Dolan , J R Gosney
Oncogene 18 ( 4) 987 -993

33
1999
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives.

A Cassidy , J P Myles , S W Duffy , T Liloglou
British Journal of Cancer 95 ( 9) 1288 -1290

24
2006
METH-2 silencing and promoter hypermethylation in NSCLC.

J R Dunn , D Panutsopulos , M W Shaw , J Heighway
British Journal of Cancer 91 ( 6) 1149 -1154

52
2004
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

S L Smith , M Gugger , P Hoban , D Ratschiller
British Journal of Cancer 91 ( 8) 1515 -1524

43
2004
Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

R J Shaw , T Liloglou , S N Rogers , J S Brown
British Journal of Cancer 94 ( 4) 561 -568

179
2006
Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom.

S W Duffy , J K Field , P C Allgood , A Seigneurin
British Journal of Cancer 110 ( 7) 1834 -1840

23
2014
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material

N G Bediaga , M P A Davies , A Acha-Sagredo , R Hyde
British Journal of Cancer 109 ( 9) 2404 -2411

24
2013